Analyst Reco. Incyte Corporation

Stocks

INCY

US45337C1027

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 15:18:18 11/06/2026 BST			5-day change	1st Jan Change
106.56 ^USD	+1.11%		+4.81%	+7.43%

12:29pm	Guggenheim Lifts Price Target on Incyte to $136 From $130, Maintains Buy Rating	MT
10:29am	William O'Neil Initiates Incyte at Buy	MT

Analyst Reco.

12:29pm	Guggenheim Lifts Price Target on Incyte to $136 From $130, Maintains Buy Rating	MT
10:29am	William O'Neil Initiates Incyte at Buy	MT
06-09	HC Wainwright Adjusts Incyte Price Target to $140 From $135, Maintains Buy Rating	MT
06-08	Oppenheimer Adjusts Price Target on Incyte to $107 From $90, Maintains Perform Rating	MT
05-22	Bernstein Initiates Incyte at Market Perform With $99 Price Target	MT
04-29	Leerink Partners Adjusts Incyte Price Target to $131 From $129, Maintains Outperform Rating	MT
04-29	Morgan Stanley Adjusts Incyte Price Target to $103 From $102, Maintains Equal Weight Rating	MT
04-29	TD Cowen Adjusts Incyte Price Target to $124 From $123, Maintains Buy Rating	MT
04-29	Stifel Nicolaus Adjusts Incyte Price Target to $123 From $120, Maintains Buy Rating	MT
04-29	Oppenheimer Adjusts Price Target on Incyte to $90 From $84, Maintains Perform Rating	MT
04-28	TD Cowen Raises Incyte Price Target to $124 From $123	MT
04-28	Morgan Stanley Adjusts Price Target on Incyte to $102 From $94, Maintains Equalweight Rating	MT
04-24	Damora Faces Upside As Fast-Follower CALR 'Should Make Bigger Splash,' RBC Says	MT
04-17	Goldman Sachs Adjusts Incyte Price Target to $100 From $98, Maintains Neutral Rating	MT
04-07	RBC Adjusts Price Target on Incyte to $95 From $92, Maintains Sector Perform Rating	MT
03-24	UBS Lowers Price Target on Incyte to $94 From $104	MT
03-05	Evercore ISI Adjusts Price Target on Incyte to $110 From $73, Maintains In Line Rating	MT
02-26	Argus Adjusts Price Target on Incyte to $115 From $100, Maintains Buy Rating	MT
02-18	Barclays Adjusts Price Target on Incyte to $117 From $116, Maintains Overweight Rating	MT
02-11	Deutsche Bank Adjusts Incyte Price Target to $98 From $70, Maintains Hold Rating	MT
02-11	Stifel Adjusts Price Target on Incyte to $120 From $119, Maintains Buy Rating	MT
02-11	TD Cowen Adjusts Price Target on Incyte to $123 From $128, Maintains Buy Rating	MT
02-11	Goldman Sachs Adjusts Price Target on Incyte to $98 From $90, Maintains Neutral Rating	MT
02-11	Morgan Stanley Raises Price Target on Incyte to $102 From $94, Keeps Equalweight Rating	MT
02-10	RBC Cuts Price Target on Incyte to $92 From $95, Keeps Sector Perform Rating	MT